• 1
    Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 80415.
  • 2
    Oscier DG, Gardiner AC, Mould SJ et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 117784.
  • 3
    Damle RN, Wasil T, Fais F et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 18407.
  • 4
    Crespo M, Bosch F, Villamor N et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 176475.
  • 5
    Caporaso N, Goldin L, Plass C et al. Chronic lymphocytic leukaemia genetics overview. Br J Hematol 2007; 139: 6304.
  • 6
    Ghia P, Stamatopoulos K, Belessi C et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005; 105: 167885.
  • 7
    Koiso H, Yamane A, Mitsui T et al. Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia. Leuk Res 2006; 30: 2726.
  • 8
    Donisi PM, Di Lorenzo N, Riccardi M et al. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy. Diagn Mol Pathol 2006; 15: 20615.
  • 9
    Rassenti LZ, Huynh L, Toy TL et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004; 351: 893901.
  • 10
    Montillo M, Hamblin T, Hallek M et al. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica 2005; 90: 3919.
  • 11
    Vasconcelos Y, Davi F, Levy V et al. Binet’s staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. J Clin Oncol 2003; 21: 392832.
  • 12
    Maloum K, Davi F, Merle-Beral H et al. Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 2000; 96: 3779.
  • 13
    Fais F, Ghiotto F, Hashimoto S et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 151525.
  • 14
    Rosenquist R, Lindstrom A, Holmberg D et al. V(H) gene family utilization in different B-cell lymphoma subgroups. Eur J Hematol 1999; 62: 1238.
  • 15
    Hamblin TJ, Davis Z, Gardiner A et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 184854.
  • 16
    Duke VM, Gandini D, Sherrington PD et al. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica 2003; 88: 125971.
  • 17
    Messmer BT, Albesiano E, Messmer D et al. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood 2004; 103: 34905.
  • 18
    Widhopf GF II, Rassenti LZ, Toy TL et al. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004; 104: 2499504.
  • 19
    Mauerer K, Zahrieh D, Gorgun G et al. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia. Br J Hematol 2005; 129: 499510.
  • 20
    Tobin G, Thunberg U, Johnson A et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003; 101: 49527.
  • 21
    Widhopf GF II, Kipps TJ. Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells. J Immunol 2001; 166: 95102.
  • 22
    Potter KN, Orchard J, Critchley E et al. Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. Blood 2003; 101: 30824.
  • 23
    Kipps TJ, Tomhave E, Pratt LF et al. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1989; 86: 59137.
  • 24
    Schroeder HW Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994; 15: 28894.
  • 25
    Tobin G, Thunberg U, Karlsson K et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004; 104: 287985.
  • 26
    Pasqualucci L, Neri A, Baldini L et al. BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. Cancer Res 2000; 60: 56448.
  • 27
    Ghia EM, Jain S, Widhopf GF II et al. Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection. Blood 2008; 111: 51018.
  • 28
    Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001.
  • 29
    Cheson BD, Bennett JM, Grever M et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 49907.
  • 30
    Jelinek DF, Tschumper RC, Geyer SM et al. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Hematol 2001; 115: 85461.
  • 31
    Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor–recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 22535.
  • 32
    Lossos IS, Tibshirani R, Narasimhan B et al. The inference of antigen selection on Ig genes. J Immunol 2000; 165: 51226.
  • 33
    Messmer BT, Raphael BJ, Aerni SJ et al. Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia. Leuk Res 2009; 33: 36876.
  • 34
    Murray F, Darzentas N, Hadzidimitriou A et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008; 111: 152433.
  • 35
    Matthews C, Catherwood MA, Morris TC et al. V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis. Leuk Res 2007; 31: 2314.
  • 36
    Nakahashi H, Tsukamoto N, Hashimoto Y et al. Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders. Cancer Sci 2009; 100: 6717.
  • 37
    Chen L, Zhang Y, Zheng W et al. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res 2008; 32: 14918.
  • 38
    Farsangi MH, Jeddi-Tehrani M, Sharifian RA et al. Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia. Leuk Lymphoma 2007; 48: 10916.
  • 39
    Moazzeni SM, Amirzargar AA, Shokri F. HLA antigens in Iranian patients with B-cell chronic lymphocytic leukemia. Pathol Oncol Res 1999; 5: 1425.
  • 40
    Tamura K, Sawada H, Izumi Y et al. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Hematol 2001; 67: 1527.
  • 41
    Kraj P, Friedman DF, Stevenson F et al. Evidence for the overexpression of the VH4-34 (VH4.21) Ig gene segment in the normal adult human peripheral blood B cell repertoire. J Immunol 1995; 154: 640620.
  • 42
    Brezinschek HP, Foster SJ, Brezinschek RI et al. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(−)/IgM+ B cells. J Clin Invest 1997; 99: 2488501.
  • 43
    Nardini E, Neri F, Vicenzi E et al. Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients. Int J Cancer 2003; 107: 95861.
  • 44
    Abramenko I, Bilous N, Kryachok I et al. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine. Exp Oncol 2007; 29: 22630.
  • 45
    Weinberg JB, Volkheimer AD, Chen Y et al. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia. Am J Hematol 2007; 82: 106370.
  • 46
    Guarini A, Chiaretti S, Tavolaro S et al. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. Blood 2008; 112: 78292.
  • 47
    Rosenwald A, Alizadeh AA, Widhopf G et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 163947.
  • 48
    Stamatopoulos K, Belessi C, Moreno C et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007; 109: 25970.
  • 49
    Tobin G, Thunberg U, Johnson A et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002; 99: 22624.
  • 50
    Degan M, Rupolo M, Bo MD et al. Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia. Clin Lymphoma 2004; 5: 1236.
  • 51
    Degan M, Bomben R, Bo MD et al. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Hematol 2004; 126: 2942.
  • 52
    Gallego A, Vargas JA, Castejon R et al. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL. Cytometry B Clin Cytom 2003; 56: 239.
  • 53
    Suarez F, Lortholary O, Hermine O et al. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006; 107: 303444.
  • 54
    Li HC, Stoicov C, Rogers AB et al. Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 2006; 12: 36371.